To determine the levels of Cx43 protein in the mouse eye, lysates were extracted from whole eyes of postnatal day 1 Gja1 Jrt/+ (n = 8) and wild-type (n = 9) mice by using a Triton-based extraction buffer containing 1% Triton-X 100, 10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% NP-40, 100 mM sodium fluoride, 100 mM sodium orthovanadate, and a protease inhibitor tablet (one tablet per 10 mL buffer; Roche, Laval, QC, Canada) at pH 7.4. Protein concentrations were measured using a BCA protein-determination kit (Thermo Scientific, Rockland, IL). Lysate samples (30 μg) were boiled for 5 minutes, subjected to 10% SDS-PAGE, and transferred to a nitrocellulose membrane. The membranes were blocked with 5% nonfat dry milk (Santa Cruz Biotechnology, Santa Cruz, CA) and 0.05% Tween 20 in PBS for 30 minutes at room temperature. Affinity-purified rabbit anti-Cx43 polyclonal (cat no. C6219; Sigma-Aldrich, St. Louis, MO) primary antibodies were incubated overnight at 4°C. The epitope used in the production of this antibody was a peptide corresponding to a C-terminal segment (amino acid residues 363-382) of the cytoplasmic domain of human/rat Cx43 with an additional N-terminal lysine. Anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibodies (1:20,000; Chemicon/Millipore, Temecula, CA) were used in parallel, to assess gel loading. After washes with PBS-Tween 20, AlexaFluor 680 secondary antibodies (1:5000; A21076; Invitrogen, Burlington, ON, Canada) and IRDye 800 (1:5000; Rockland, Gilbertsville, PA) were used. Membranes were visualized with an infrared imaging system (Odyssey; LiCor, Lincoln, NE). Densitometry analysis of unsaturated images was performed with commercial software (Quantity ONE; Bio-Rad, Mississauga, ON, Canada) and protein levels were normalized to GAPDH.